John Jabez David, Patel Tirath, Kharat Monica, Patel Jeet HansalKumar, Al Hooti Jubran, Syeda Zoya Riyaz, Khare Rohit Anil, Bhatia Sonya, Ibrahim Amin, Bellamkonda Arjun, Anand Nikhilesh, Gadad Bharathi S
Department of Surgery, Malla Reddy Institute of Medical Sciences, Hyderabad, 500055, India.
Department of Surgery, Trinity Medical Sciences University School of Medicine, Saint Vincent, Saint Vincent, Grenadines, 30075, Saint Vincent and the Grenadines.
J Cardiothorac Surg. 2025 Aug 20;20(1):343. doi: 10.1186/s13019-025-03519-2.
The systematic review determines whether valve-sparing surgeries improve patient outcomes compared with non valve-sparing surgeries for tetralogy of Fallot. Although previous studies have reported superior outcomes in valve-sparing surgery, no systematic review has compared these outcomes with those of nonsurgical surgical methods.
In the present research, we address this gap in the literature by comparing valve-sparing and non valve-sparing surgery outcomes. PubMed, PubMed Central, and Medline served as the databases for data collection; following the PRISMA guidelines, a comprehensive search strategy identified relevant articles for the review; the search strategy included Medical Subject heading (MeSH) terms and important keywords. The search strategy initially revealed seventy articles; these were further screened by title and abstract and refined to fifteen articles for full-text analysis. For further full-paper analysis, eight articles were refined and formed the basis of our analysis. There was a severe limitation of high-quality clinical trials and prospective studies, and we included any good-quality papers that passed the quality check and adhered to the inclusion and exclusion criteria.
The number of patients included in this study was 962 from 8 studies; 351 underwent valve-sparing surgery, and 611 underwent TOF correction via non valve-sparing methods. This systematic review provides encouraging evidence that suggests better outcomes for valve-sparing surgery. Most studies have consistently reported a significantly lower prevalence of moderate or severe pulmonary regurgitation in valve-sparing surgeries. Since the valve-sparing technique allows for the preservation of the native valves, it allows for better growth of the pulmonary valve. Additionally, most studies reported that valve-sparing surgeries significantly improved proper ventricular function, but mixed results regarding reintervention have been reported. The risk of complications was similar between the surgical modalities; valve-sparing repair has consistently outperformed other surgical modalities. Low birth weight remains a prominent risk factor even for valve-sparing surgery.
In summary, the evidence presented in this review strongly supports the use of valve-sparing surgery for improved patient outcomes. This systematic review highlights the benefits of valve-sparing surgery over other surgical techniques. It can be a foundation for clinical practice that allows surgeons to make better, informed decisions about patient care. The limitations of the lack of studies found when this review was conducted can further guide other research, strengthen the evidence, and lead to better patient care.
本系统评价旨在确定与非保留瓣膜手术相比,保留瓣膜手术是否能改善法洛四联症患者的预后。尽管先前的研究报告了保留瓣膜手术的更好预后,但尚无系统评价将这些预后与非保留瓣膜手术方法的预后进行比较。
在本研究中,我们通过比较保留瓣膜和非保留瓣膜手术的预后,填补了文献中的这一空白。PubMed、PubMed Central和Medline作为数据收集的数据库;按照PRISMA指南,采用全面的检索策略确定相关文章进行综述;检索策略包括医学主题词(MeSH)和重要关键词。检索策略最初检索到70篇文章;通过标题和摘要进一步筛选,最终确定15篇文章进行全文分析。为进行进一步的全文分析,筛选出8篇文章并作为我们分析的基础。高质量的临床试验和前瞻性研究存在严重局限性,我们纳入了所有通过质量检查并符合纳入和排除标准的高质量论文。
本研究纳入的患者来自8项研究,共962例;351例行保留瓣膜手术,611例通过非保留瓣膜方法进行法洛四联症矫正。本系统评价提供了令人鼓舞的证据,表明保留瓣膜手术的预后更好。大多数研究一致报告,保留瓣膜手术中中度或重度肺动脉反流的发生率显著更低。由于保留瓣膜技术能够保留天然瓣膜,有利于肺动脉瓣更好地生长。此外,大多数研究报告称,保留瓣膜手术显著改善了右心室功能,但关于再次干预的结果存在分歧。两种手术方式的并发症风险相似;保留瓣膜修复术的表现始终优于其他手术方式。低出生体重即使对于保留瓣膜手术来说仍是一个突出的危险因素。
总之,本综述提供的证据有力支持采用保留瓣膜手术以改善患者预后。本系统评价突出了保留瓣膜手术相对于其他手术技术的优势。它可为临床实践提供依据,使外科医生能够就患者护理做出更好、更明智的决策。本综述进行时发现的研究不足的局限性可进一步指导其他研究,加强证据,并带来更好的患者护理。